SCHEMBL9609407

SCHEMBL9609407

COc1ccc2c(c1)c(=O)c1cc([S+](c3ccc(O)cc3)c3ccc(O)cc3)ccc1n2C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 1/20 0.47
▸ MAPT P10636 6/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ ALDH1A1 P00352 7/20 0.47
▸ KDM4E B2RXH2 6/20 0.47
▸ HPGD P15428 5/20 0.47
▸ L3MBTL1 Q9Y468 3/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ HTT P42858 1/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.42
▸ BCHE P06276 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ RAB9A P51151 3/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ APAF1 O14727 1/20 0.40
▸ PABPC1 P11940 1/20 0.40
▸ PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609395 0.83 HTT (0.48) MAPTALDH1A1KDM4EHPGDL3MBTL1
SCHEMBL9609414 0.82 MAPK8 (0.39) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL9609402 0.77 RXFP1 (0.43) MAPTSMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL9609398 0.75 ALKBH5 (0.44) RETMAPTALDH1A1KDM4EHPGD
SCHEMBL6152266 0.75 L3MBTL1 (0.76) MAPTSMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL12692736 0.75 ALDH1A1 (0.57) MAPTSMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL9609408 0.75 RXFP1 (0.41) RETMAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL11047658 0.72 ALDH1A1 (0.81) MAPTSMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL24155343 0.70 L3MBTL1 (0.52) MAPTSMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL9609428 0.69 ATM (0.62) MAPTALDH1A1KDM4EHPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073854-B2 Aromatic sulfonium salt compound ADEKA CORPORATION (JP) 2015-07-07 — — US disclosed
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2012-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND F12, ASIC1, SPIN1 RET 876/4885MAPT 1744/4885SMN1; SMN2 2549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback